Aparna Pharmaceuticals secures EUGMP certification for Pydibhimavaram facility

Pharma Accelerates AI Adoption as Transparency and Traceability Take Center Stage

DRRA22 minutes ago 0

Tariff pause eases pressure on drug companies

DRRA2 hours ago 0

Natco wins patent battle to launch generic ‘Risdiplam’

DRRA2 hours ago 0

FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma

DRRA3 hours ago 0